Found: 7
Select item for more details and to access through your institution.
Astaxanthin protects against pirarubicin-induced H9c2 cardiomyocytes by adjusting microRNA-494-3p-mediated MDM4/p53 signalling pathway.
- Published in:
- Journal of Pharmacy & Pharmacology, 2023, v. 75, n. 12, p. 1521, doi. 10.1093/jpp/rgad084
- By:
- Publication type:
- Article
LncRNA Miat knockdown enhances pirarubicin‐mediated anticancer sensitivity in breast cancer cells.
- Published in:
- Environmental Toxicology, 2024, v. 39, n. 1, p. 23, doi. 10.1002/tox.23940
- By:
- Publication type:
- Article
LncRNA Miat knockdown protects against pirarubicin‐induced cardiotoxicity by targeting miRNA‐129‐1‐3p.
- Published in:
- Environmental Toxicology, 2023, v. 38, n. 11, p. 2751, doi. 10.1002/tox.23910
- By:
- Publication type:
- Article
MiR‐494‐3p aggravates pirarubicin‐induced cardiomyocyte injury by regulating MDM4/p53 signaling pathway.
- Published in:
- Environmental Toxicology, 2023, v. 38, n. 10, p. 2499, doi. 10.1002/tox.23888
- By:
- Publication type:
- Article
Adenylate cyclase 1 knockdown attenuates pirarubicin‐induced cardiotoxicity.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2024, v. 51, n. 10, p. 1, doi. 10.1111/1440-1681.13920
- By:
- Publication type:
- Article
Circular RNA circ_0000043 promotes endometrial carcinoma progression by regulating miR-1271-5p/CTNND1 axis.
- Published in:
- Archives of Gynecology & Obstetrics, 2021, v. 303, n. 4, p. 1075, doi. 10.1007/s00404-020-05849-z
- By:
- Publication type:
- Article
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer.
- Published in:
- Breast Cancer (13406868), 2023, v. 30, n. 3, p. 379, doi. 10.1007/s12282-023-01433-w
- By:
- Publication type:
- Article